Correlation Between EnVVeno Medical and Neuropace

Can any of the company-specific risk be diversified away by investing in both EnVVeno Medical and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnVVeno Medical and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between enVVeno Medical Corp and Neuropace, you can compare the effects of market volatilities on EnVVeno Medical and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnVVeno Medical with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnVVeno Medical and Neuropace.

Diversification Opportunities for EnVVeno Medical and Neuropace

-0.01

Correlation Coefficient

EnVVeno Medical  Neuropace

Good diversification

The 3 months correlation between EnVVeno and Neuropace is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding enVVeno Medical Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and EnVVeno Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enVVeno Medical Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of EnVVeno Medical i.e., EnVVeno Medical and Neuropace go up and down completely randomly.

Pair Corralation between EnVVeno Medical and Neuropace

Given the investment horizon of 90 days enVVeno Medical Corp is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, enVVeno Medical Corp is 1.13 times less risky than Neuropace. The stock trades about -0.14 of its potential returns per unit of risk. The Neuropace is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  739.00  in Neuropace on August 31, 2024 and sell it today you would earn a total of  286.00  from holding Neuropace or generate 38.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

enVVeno Medical Corp  vs.  Neuropace

enVVeno Medical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Neuropace

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with EnVVeno Medical and Neuropace

The main advantage of trading using opposite EnVVeno Medical and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnVVeno Medical position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind enVVeno Medical Corp and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.